"OncoCare Cancer Centre (Gleneagles) sees patients who are either suspected of having or are already diagnosed with cancer. We help them navigate the complexities of getting their diagnosis confirmed, understand the extent of disease and treatment options; be it surgery, chemotherapy, radiation therapy or combined therapies, and walk with them through their treatment journey. To date, OncoCare has grown to encompass 7 cancer centres comprising of specialists clinics with adjoining chemotherapy suites. The centres are designed around the patient, catering for comfort, privacy and efficiency when administering treatment."

During the past decade, Oncocare Cancer Centre conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 5 clinical trials were completed, i.e. on average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Oncocare Cancer Centre" #1 sponsor was "Amgen" with 1 trials, followed by "Apollomics Inc." with 1 trials sponsored, "Arcus Biosciences, Inc." with 1 trials sponsored, "Ariad Pharmaceuticals" with 1 trials sponsored and "Astellas Pharma Inc" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oncocare Cancer Centre" #1 collaborator was "BeiGene, Ltd." with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Oncocare Cancer Centre" are "Lung Cancer" (3 trials), "Gastric Cancer" (2 trials), "NSCLC" (2 trials), "Non Small Cell Lung Cancer" (2 trials) and "Advanced Cancer" (1 trials). Many other conditions were trialed in "Oncocare Cancer Centre" in a lesser frequency.

Most popular intervention types in "Oncocare Cancer Centre" are "Drug" (12 trials), "Biological" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "5-Fluorouracil" (2 trials), "Oxaliplatin" (2 trials), "Placebo" (2 trials), "APL-101 Oral Capsules" (1 trials) and "Alpelisib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Oncocare Cancer Centre" are 11 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Oncocare Cancer Centre". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Oncocare Cancer Centre, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Oncocare Cancer Centre, 2 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Oncocare Cancer Centre has several departments that took part in Clinical trials: "OncoCare Cancer Centre- Gleneagles Medical Centre" - 2 trials